What Researchers Did
Researchers evaluated the use of Vacuum Assisted Closure (VAC) therapy in six male patients with Fournier's gangrene over a three-year period.
What They Found
The six male patients, with a mean age of 54.6 years, all had diabetes and received VAC therapy after initial surgical debridement. VAC therapy reduced the number of dressings and hospital length of stay, and colostomies were reversed in all patients within three months. One patient also underwent successful secondary reconstructive surgery.
What This Means for Canadian Patients
Canadian patients with Fournier's gangrene might benefit from Vacuum Assisted Closure (VAC) therapy to potentially reduce hospital stays and the frequency of dressing changes. This approach could also facilitate earlier reconstructive surgery, improving quality of life.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this study is its small sample size of only six patients, which limits the generalizability of the findings.